BARDA’s Project NextGen Selects BIE

By /

ASPR/BARDA awards $500 million for Project NextGen technologies that advance innovative next-generation vaccine and therapeutics platforms. BioInfoExperts is among the recipients, with $4 million to provide genomic sequencing of COVID-19. For more information visit: https://medicalcountermeasures.gov/nextgen/